🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase II Study Evaluating the Efficacy and Safety of LM-302 in Combinatio...
Status
Recruiting
Location
Zhongshan Hospital Fudan University
Start Date
2024-07-31
Trial ID
NCT06587425
Treatments Being Tested
In this study, the investigators will use Tislelizumab combined with LM-302...
Status
Recruiting
Location
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Start Date
2026-04-21
Trial ID
NCT07569068
Treatments Being Tested
A Phase I/II, Open-Label, Multiple Centre Clinical Study to Evaluate the Sa...
Status
Completed
Location
The Alfred
Start Date
2022-05-10
Trial ID
NCT05188664
Treatments Being Tested
In this study, the investigators will use LM-302 and S-1 plus intraperitone...
Status
Recruiting
Location
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Start Date
2026-04-17
Trial ID
NCT07556640
Treatments Being Tested
This study is to evaluate the efficacy of the LM-302 Combination With Other...
Status
Recruiting
Location
Shanghai East Hospital
Start Date
2023-07-27
Trial ID
NCT05934331
In this clinical study, we will evaluate the efficacy and safety of cardoni...
Status
Active Not Recruiting
Location
Zhongshan hospital, Fudan University
Start Date
2023-08-01
Trial ID
NCT05994001
Treatments Being Tested
This study primarily evaluates the efficacy and safety of the LM-302 plus t...
Status
Recruiting
Location
Anhui Provincial Cancer Hospital
Start Date
2026-04-15
Trial ID
NCT07385703
Treatments Being Tested
In this phase 2 study, we combined Cadonilimab, LM-302, and S-1 combined wi...
Status
Recruiting
Location
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Start Date
2025-02-25
Trial ID
NCT06519591
Treatments Being Tested
A Phase I, First-in-Human, Open-Label, Dose Escalation and Expansion Study ...
Status
Completed
Location
Local Institution - 0013
Start Date
2021-12-29
Trial ID
NCT05001516
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy and safety of L...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-08-10
Trial ID
NCT07108504
Treatments Being Tested